Utilizing a Protocol Cost Saving Analysis to Reduce Drug Development Costs

August 21, 2018

Over the years, studies have been conducted to ascertain the cost of research and development (“R&D”) required to bring a new drug to market. Experts disagree on the exact amount, but the consensus is that the figure is in the hundreds of millions to over a billion dollars. Pharmaceutical companies, biotech firms and anyone in the business of developing new therapeutics knows there is significant pressure to reduce the cost of R&D, while still delivering safe and effective treatments that alleviate symptoms or cure a medical condition.

Spotlight

Christies Care Ltd

Consultus Care & Nursing is a nationwide specialist in the provision of Live-in Carers and Nurses. Established in 1962, we have decades of experience in providing quality live-in care for people who want a real alternative to care homes, inconsistent daily care and extended hospital stays. We offer our clients the choice to receive one-to-one care or nursing within the comfort and familiarity of their own home. Live-in Care For over 50 years we have been providing Live-in Carers to support people who wish to maintain an independent lifestyle in their own home. Our Live-in Carers offer individuals or couples a welcome and reassuring alternative to care homes. It’s a one-to-one service shaped by each individual's situation and needs, extending their independence and enabling daily freedom of choice. Many healthcare professionals agree their patients recover more quickly following illness or an operation when they’re in the comfort of their own homes. Our carers provide help with personal

OTHER WHITEPAPERS
news image

WILL PHARMA COMMIT TO DELIVERING AFFORDABLE THERAPEUTICS AGAINST COVID-19?

whitePaper | April 8, 2020

EPHA is a change agent – Europe’s leading NGO alliance advocating for better health. We are a dynamic member-led organisation, made up of public health civil society, patient groups, health professionals, and disease groups working together to improve health and strengthen the voice of public health in Europe.

Read More
news image

Pharma R&D Annual Review 2022 Navigating the Landscape

whitePaper | May 7, 2022

Citeline, Welcome to Pharmaprojects' 2022 reviews of trends in pharmaceutical R&D. Take a look at the evolution of pharma R&D and in this article, examine the state of play at the start of 2022.

Read More
news image

Assessing drug target association from biological evidences

whitePaper | July 7, 2022

The full drug target profile identification is many times a necessary step in drug development process. Recently, the move to a more holistic approach in drug discovery has resulted in the increasing use of cell-based assays to discover new biologically active small molecules.

Read More
news image

Choosing the Right Temperature Monitoring Solution

whitePaper | April 24, 2023

Globally, pharmaceutical regulators are becoming attuned to cold chain issues as biologics, vaccines, and other temperature‐sensitive products are commercialized for a global clientele. Many regulators now recommend including temperature monitoring technology in every cold chain shipment.

Read More
news image

How IPD Can Deliver for Life Sciences

whitePaper | January 1, 2020

Life sciences is facing a number of disruptors: novel cell and gene therapies that will revolutionize manufacturing, drug delivery and pricing models; a battle for the best and brightest talent; political and public pressure on the price of medication as well as the implications of the fourth industrial revolution. These factors combine to make investment decisions more challenging. With life sciences firms placing an increasing focus on the most efficient use of capital and shorter delivery times, project delivery providers are striving to come up with leaner and more innovative strategies and solutions to meet these needs. Integrated Project Delivery (IPD) is one such strategy.

Read More
news image

Blockchain technology in the pharmaceutical industry

whitePaper | March 11, 2022

Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry.

Read More

Spotlight

Christies Care Ltd

Consultus Care & Nursing is a nationwide specialist in the provision of Live-in Carers and Nurses. Established in 1962, we have decades of experience in providing quality live-in care for people who want a real alternative to care homes, inconsistent daily care and extended hospital stays. We offer our clients the choice to receive one-to-one care or nursing within the comfort and familiarity of their own home. Live-in Care For over 50 years we have been providing Live-in Carers to support people who wish to maintain an independent lifestyle in their own home. Our Live-in Carers offer individuals or couples a welcome and reassuring alternative to care homes. It’s a one-to-one service shaped by each individual's situation and needs, extending their independence and enabling daily freedom of choice. Many healthcare professionals agree their patients recover more quickly following illness or an operation when they’re in the comfort of their own homes. Our carers provide help with personal

Events